[ad_1]
The World Health Organization (WHO) reported that there is no evidence that Remdesivir, the antiviral used in the treatment of the new type of coronavirus (Covid-19), helps Covid-19 patients to survive and their respiratory needs.
“IT IS USED MORE WHEN GOING TO TREAT PATIENTS IN THE HOSPITAL”
In a written statement from the WHO, “Remdesivir has gained worldwide attention as a potentially effective treatment method for severe cases of Covid-19 and is increasingly being used to treat patients in hospital. But its role in clinical practice it remains unclear. “
In the statement, it was noted that according to the results of 4 different studies, which the WHO based on 7 thousand patients diagnosed with Covid-19, the drug was not recommended for hospitalized patients with the diagnosis of Kovid-19, and there were no evidence that it helped patients survive and respiratory needs, regardless of how ill they were. .
WHO THE PRESIDENT ALSO MADE ANNOUNCEMENT
WHO Director-General Dr. Tedros Adhanom Ghebreyesus stated on October 16 that the antiviral drug “Remdesivir,” the combination of hydroxychloroquine and lopinavir / ritonavir used in the treatment of AIDS, had little or no effect on deaths from Covid- 19 and hospital stay.
